ControlRad™ Secures $15 Million Series B Financing, Expands Board of Directors
Financing Round Led by Questa Capital to Fuel Commercialization of ControlRad Trace Mobile C-arm Radiation Reduction Technology
Medical Device Industry Veterans Ryan Drant and Tim Patrick Join Board
ATLANTA, October 2, 2019 – ControlRad, Inc., a privately held medical technology company focused on dramatically reducing unnecessary radiation exposure during fluoroscopically guided procedures (FGP), today announced it completed $15 million in financing and that medical device industry veterans Ryan Drant and Tim Patrick have joined its board of directors. The Series B round, which was led by Questa Capital, will be used for fueling the commercial launch of the innovative ControlRad Trace system.